Fairchem Organics Limited

NSE:FAIRCHEMOR.NS

1003.5 (INR) • At close July 1, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q3
Revenue 1,207.8071,135.7081,386.1861,649.2831,515.081,476.5341,518.7771,603.4951,515.0771,022.2911,682.5852,249.4171,773.6981,582.7191,676.6171,389.7641,590.9351,068.293948.555350.118891.636801.359
Cost of Revenue 1,107.601855.0371,052.2631,359.9071,159.061,069.8511,139.0211,267.6771,104.084815.5151,362.8431,624.7021,436.481,154.4281,155.889900.4091,166.86716.507597.612244.683603.691550.16
Gross Profit 100.206280.671333.923289.376356.02406.683379.756335.818410.993206.776319.742624.715337.218428.291520.728489.355424.075351.786350.943105.435287.945251.199
Gross Profit Ratio 0.0830.2470.2410.1750.2350.2750.250.2090.2710.2020.190.2780.190.2710.3110.3520.2670.3290.370.3010.3230.313
Reseach & Development Expenses 00001.6260001.9480001.9390001.539000.4222.5980
General & Administrative Expenses 0000174.55200072.21100043.57800067.393004.08234.6190
Selling & Marketing Expenses 00002.4280002.5970003.5350001.948006.9141.1520
SG&A 82.4220097.456176.9871.77378.05551.64174.80860.6173.20248.65547.11345.06644.21455.14769.34137.9848.93110.99635.77134.89
Other Expenses 0229.043333.92302.8132.4524.5511.5231.6882.7190.0332.837-2.840.9130.3654.058-0.1690.0730.1070.006-63.7491.366
Operating Expenses 82.422229.043333.92397.456184.51233.157233.121241.075239.923190.891247.135243.005167.704233.271220.678177.737164.967155.729213.25294.26197.612148.93
Operating Income 17.78451.62861.148191.92171.51175.978151.18694.743359.57318.60472.64381.71169.514195.02300.05311.618277.01196.057137.79813.639211.35102.269
Operating Income Ratio 0.0150.0450.0440.1160.1130.1190.10.0590.2370.0180.0430.170.0960.1230.1790.2240.1740.1840.1450.0390.2370.128
Total Other Income Expenses Net -6.661-4.468-6.393-5.754-3.361-7.208-8.482-12.003-199.995-6.5-16.134-21.221-17.249-14.397-19.864-12.288-18.97-16.014-15.516-14.857-23.34-15.733
Income Before Tax 11.12347.1654.755186.166159.58166.318138.15382.74159.5789.38556.473360.489152.265180.623280.186299.33240.138180.043122.175-3.683166.99386.536
Income Before Tax Ratio 0.0090.0420.040.1130.1050.1130.0910.0520.1050.0090.0340.160.0860.1140.1670.2150.1510.1690.129-0.0110.1870.108
Income Tax Expense 5.18611.98214.64947.64440.9743.0135.29721.51440.9743.29916.44390.19439.83346.08571.21276.2151.83946.01331.6-1.78536.26621.216
Net Income 5.93735.17840.106138.522117.613123.308102.85661.226118.6046.08640.03270.295112.432134.538208.974223.12188.299134.0390.575-1.898130.72765.32
Net Income Ratio 0.0050.0310.0290.0840.0780.0840.0680.0380.0780.0060.0240.120.0630.0850.1250.1610.1180.1250.095-0.0050.1470.082
EPS 0.462.73.0810.649.119.477.94.79.110.473.0720.768.6310.3316.0517.1414.4610.296.96-0.1510.075.03
EPS Diluted 0.462.73.0810.649.119.477.94.79.110.473.0720.768.6310.3316.0517.1414.4610.296.96-0.1510.075.03
EBITDA 46.62683.08791.351220.145187.611199.961172.944117.808194.03439.46693.142403.426187.485214.096318.06332.628277.865212.755160.00127.433200.933119.684
EBITDA Ratio 0.0390.0730.0660.1330.1240.1350.1140.0730.1280.0390.0550.1790.1060.1350.190.2390.1750.1990.1690.0780.2250.149